Isidro Salusky, MD
Enriched profileDistinguished Professor of Pediatrics; Chief, Division of Pediatric Nephrology; Director, Pediatric Dialysis Program · David Geffen School of Medicine at UCLA
Isidro Salusky is Distinguished Professor of Pediatrics; Chief, Division of Pediatric Nephrology; Director, Pediatric Dialysis Program at David Geffen School of Medicine at UCLA. OpenAlex indexes 389 publications with 18,607 citations (h-index 62); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Isidro B. Salusky, MD, is Distinguished Professor of Pediatrics at David Geffen School of Medicine at UCLA. The public record shows 389 publications with 18,607 citations (h-index 62), centered on Parathyroid Disorders and Treatments, Dialysis and Renal Disease Management, Vitamin D Research Studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 9 companies, 9 NIH-funded awards (1986–2026).
- Most recent indexed publication: 2026 · JBMR plus
- Top research focus: Parathyroid Disorders and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 214.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Ferric Citrate and Chronic Kidney Disease in Children
Sponsor: University of California, Los Angeles
- How Bone is Made in Children Receiving Dialysis
Sponsor: University of California, Los Angeles
- Regulation of Bone Formation in Renal Osteodystrophy
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Ultragenyx Pharmaceutical Inc.Program year20251 payment
- AKEBIA THERAPEUTICS INCProgram year20251 payment
- Apellis Pharmaceuticals, Inc.Program year20252 payments
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Potassium supplement100%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Phosphate binder therapy and chronic kidney disease in children
University of California Los Angeles
FY2026$761,975U01DK122013 - Phosphate binder therapy and chronic kidney disease in children
University of California Los Angeles
FY2026$52,575U01DK122013 - Phosphate binder therapy and chronic kidney disease in children
University of California Los Angeles
FY2026$37,050U01DK122013
Congress activity
Updated 27 Aug 2026
1 congress contribution (2023) across ASH per OpenAlex. The most recent:
- <i>Serum Ferritin Reflects Bone Marrow Iron Stores in Children with End Stage Kidney Disease</i>
ASH Annual Meeting
ASH2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.
Journal of bone and mineral research
Article2022 - A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
Pediatric nephrology (Berlin, Germany)
Review2022
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 05Suppression of Iron-Regulatory Hepcidin by Vitamin D345 citations2013
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/isidro-salusky-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Isidro-B-Salusky-2218873751
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- Pediatric residency
Dr. Pedro de Elizalde Hospital, Buenos Aires, Argentina
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- President
International Pediatric Nephrology Association (IPNA) (also served as Councilor and Treasurer)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - Member
American Society of Nephrology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucla.edu ↗
Secondary affiliations
appointments beyond the home institution- Workforce Development Program Director
Training Program in Translational Science, UCLA Clinical and Translational Science Institute (CTSI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ctsi.ucla.edu ↗ - Member
Medical/Scientific Advisory Board, University Kidney Research Organization (UKRO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ukrocharity.org ↗ - Member
Scientific Advisory Board, OPKO Health, Inc. (Renal Division)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Finn, MD
David Geffen School of Medicine at UCLA
Edward Garon, MD
David Geffen School of Medicine at UCLA
Donald Tashkin, MD
David Geffen School of Medicine at UCLA
Aditya Bardia, MD
David Geffen School of Medicine at UCLA